Christian Vissers, MD
Orthopaedic Surgery · Gainesville, TXNPI 1174516876
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Stryker at 54.8% of the total. Reporting peaked in 2023 at $336 and has fallen 58.6% since, to $139 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in TX, where the typical reported total is $4,671.
Across 61 payments — averaging $20.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$689
- Johnson & Johnson$267
- Bioventus LLC$102
- Pacira Pharmaceuticals Incorporated$60
- Orthofix Medical, Inc.$45
- Smith+Nephew$24
- plus $69 from 4 others
What the payments were for
- Food & beverage$1,256100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 37 | $689 |
| Johnson & Johnson(2 entities) | 10 | $267 |
| Bioventus LLC | 4 | $102 |
| Pacira Pharmaceuticals Incorporated | 2 | $60 |
| Orthofix Medical, Inc. | 3 | $45 |
| Smith+Nephew | 1 | $24 |
| Pylant Medical | 1 | $21 |
| Omeros Corporation | 1 | $17 |
| Molnlycke Health Care US, LLC | 1 | $16 |
| Abbott | 1 | $15 |
How this compares
$1,256 in reported general payments places this provider in the 25th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 164 | $1,479 |
| Tramadol Hcl | 116 | $409 |
| Gabapentin | 34 | $331 |
| CefuroximeCefuroxime Axetil | 11 | $155 |
| Pregabalin | 15 | $146 |
| Methylprednisolone | 20 | $123 |
| Meloxicam | 47 | $95 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 11 | $79 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Gainesville
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
- Robert GrahamAustin$6.3M
- Richard JonesDallas$6.3M
- Stefan KreuzerHouston$6.2M
- Michael WirthSan Antonio$4.5M
- Stephen IncavoHouston$4.3M
- Thomas EdwardsHouston$4.1M
- James BrodskyDallas$2.5M
- Robert SchmidtFort Worth$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.